Oncology Part 2
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
Part two of our look at cancer research at VA includes a conversation with Dr. Khalil Ahmend, Professor of Laboratory Medicine and Pathology at the University of Minnesota. Dr. Ahmed has been a Senior Research Career Scientist, Minneapolis VA since 1978. For over forty years, Dr. Ahmed’s long-standing interest has been in protein CK2 (formerly casein kinase 2 or II). He investigation of its therapeutic targeting for cancer therapy and how treatments might be effective for stopping progression to resistant growth or improving response setting the stage for potential ground-breaking translation into the clinic.
No reviews yet